Blog

As we at Yaohai Bio-Pharma look toward 2026, the landscape of biologics formulation development is poised for significant innovation and efficiency improvements. With rapid advances in

Optimizing downstream process development is a critical step to ensure the production of high-quality biologics, especially in the context of increasing complexity of modern protein therapeutics.